bims-lypmec Biomed News
on Lysosomal positioning and metabolism in cardiomyocytes
Issue of 2026–11–22
four papers selected by
Satoru Kobayashi, New York Institute of Technology



  1. EMBO Mol Med. 2026 Nov 17.
      Mitochondria and lysosomes are central regulators of cellular metabolism, nutrient sensing, cellular quality control, and stress adaptation. Although traditionally studied as independent organelles, it is now evident that they operate as an integrated functional network through multiple modes of communication, including membrane contact sites, signaling pathways, and selective vesicular trafficking. Disruption of this crosstalk is increasingly recognized as a common feature of mitochondrial disorders, lysosomal storage diseases, neurodegeneration, cardiovascular disease, and aging, highlighting its importance for cellular and tissue homeostasis. While mitophagy has long been considered the principal interface between mitochondria and lysosomes, recent discoveries have revealed a much broader communication landscape in which bidirectional signaling, ion exchange, lipid transfer, and mitochondria-derived vesicles coordinate organelle function independently of bulk degradation. In this Review, we discuss the molecular mechanisms that mediate mitochondria-lysosome communication, emphasizing emerging concepts in inter-organelle signaling and membrane contact biology. We further examine how disruption of these pathways contributes to human disease and consider the growing evidence that restoring mitochondria-lysosome communication, rather than targeting either organelle in isolation, represents a promising therapeutic strategy.
    DOI:  https://doi.org/10.1038/s44321-026-00556-9
  2. J Diabetes. 2026 Nov;pii: e70299. [Epub ahead of print]18(11):
      Diabetic cardiomyopathy (DCM) is a diabetes-specific myocardial disorder, characterized by structural and functional abnormalities of the heart independent of coronary artery disease, hypertension, or valvular pathology. Metabolic abnormalities are now understood to play pivotal roles in DCM pathogenesis. Chronic hyperglycemia and insulin resistance disrupt cardiac energy metabolism, shifting myocardial substrate utilization from glucose to fatty acids. These metabolic disorders lead to imbalances in intracellular metabolite abundance, which, in turn, induce abnormalities in various biochemical reactions involving these metabolites, including post-translational modifications (PTMs) of proteins. The strong correlation between metabolism and protein PTMs has led to the concept of metabolically coupled protein modifications (MCPMs). In this narrative review, we define strict MCPMs as PTMs that directly use metabolites as substrates, and we also discuss metabolism-related PTMs such as phosphorylation and ROS/RNS-mediated modifications. We summarize reported roles of MCPMs in DCM, distinguish evidence levels, and outline major issues for future research.
    Keywords:  O‐GlcNAcylation; diabetic cardiomyopathy (DCM); lactylation; metabolism‐coupled protein modification (MCPM); post‐translational modifications (PTMs); succinylation
    DOI:  https://doi.org/10.1111/1753-0407.70299
  3. J Cell Biol. 2026 Dec 07. pii: e202505037. [Epub ahead of print]225(12):
      Lysosomes are essential for cell survival but are highly susceptible to pathological stressors. Thus, the ability to initiate an acute damage response and promote recovery is critical for maintaining cellular homeostasis. Although studies have advanced understanding of acute responses to lysosomal injury, the mechanisms governing the recovery stage and how this phase differs from the initial injury response remain poorly defined. Here, we identify a distinct response during the recovery stage. We provide the first evidence that recovery from acute damage triggers processing body (PB) formation, membraneless biomolecular condensates. Mechanistically, PBs are selectively induced during recovery, but not during acute damage, through interactions with stress granules (SGs), distinct membraneless biomolecular condensates formed upon acute injury. Functional analyses reveal that PBs promote lysosomal quality and cell survival by collaborating with SGs. Together, these findings establish PBs as central effectors of the lysosomal recovery program and underscore the broader relevance of biomolecular condensates in cellular responses to lysosomal damage and related diseases.
    DOI:  https://doi.org/10.1083/jcb.202505037
  4. Anal Chem. 2026 Nov 17. 98(45): 32086-32101
      Research on lysosomal composition and function is critical for understanding cellular homeostasis and pathogenesis of diverse diseases, including cancer. However, current isolation methods often require millions of input cells, limiting their application to rare cell populations or clinical samples. Here, we present Lysolation, a high-specificity antibody-based isolation method optimized for low cell numbers. By combining digitonin-mediated selective plasma membrane permeabilization with immunocapture targeting the lysosomal membrane protein NOX2, we developed both magnetic bead- and plate-based isolation formats. We first identified clone 7D5 as the superior antibody for capturing native lysosomal NOX2 across multiple cell types. In the bead-based workflow, we demonstrated near-exhaustive recovery of lysosomes (>99.5%) even from targets with low epitope density. To further downscale input requirements, we implemented a plate-based system combined with papain-mediated proteolytic release, achieving an isolation efficiency of 60.1% from as few as 15,000 cells. Overall, Lysolation provides a robust, tag-free platform for the isolation of intact, functional lysosomes from limited clinical samples and rare material, bridging the gap between standard biochemical assays and low-input sample availability.
    Keywords:  NOX2; bead-based isolation; immunocapture; lysosome enrichment; plate format; small input
    DOI:  https://doi.org/10.1021/acs.analchem.6c01372